BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21805032)

  • 1. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin ameliorates acute radiation proctitis in mice by regulating AKT/MAPK/NF-κB/VEGF pathways.
    Gao J; Li Y; Chen J; Feng W; Bu J; Lu Z; Wang J
    Int Immunopharmacol; 2024 May; 132():111945. PubMed ID: 38555816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.
    Zhou L; Qi L; Jiang L; Zhou P; Ma J; Xu X; Li P
    AAPS J; 2014 Mar; 16(2):246-57. PubMed ID: 24424498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma.
    Lee HZ
    Br J Pharmacol; 2001 Sep; 134(1):11-20. PubMed ID: 11522592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrosylcobalamin potentiates the anti-neoplastic effects of chemotherapeutic agents via suppression of survival signaling.
    Bauer JA; Lupica JA; Szugye H; Morrison BH; Haney RM; Masci RK; Lee RM; Didonato JA; Lindner DJ
    PLoS One; 2007 Dec; 2(12):e1313. PubMed ID: 18074035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of liriopesides B in combination with gemcitabine on human pancreatic cancer cells.
    Hong P; Wu M; Wei X; Xu X; Wu P; Gan L; Wu R; Jin J; Zhang K; Li D; Chen M; Wong W; Liu W; Zheng X
    Bioorg Chem; 2024 Jan; 142():106937. PubMed ID: 37913583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aloe-Emodin Isolated from
    He MT; Nguyen QN; Cho EJ; Kim SH; Park S; Park JY; Lee S; Kang KS
    J Diet Suppl; 2024; 21(3):389-407. PubMed ID: 38062982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel silicene-mesoporous silica nanoparticles conjugated gemcitabine induced cellular apoptosis via upregulating NF-
    Chen Y; Cheng CS; Yang P; Dong S; Chen L
    Nanotechnology; 2024 Apr; 35(25):. PubMed ID: 38452386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-assisted extraction of emodin from Rheum officinale Baill and its antibacterial mechanism against Streptococcus suis based on CcpA.
    Bai J; Xie Y; Li M; Huang X; Guo Y; Sun J; Tang Y; Liu X; Wei C; Li J; Yang Y
    Ultrason Sonochem; 2024 Jan; 102():106733. PubMed ID: 38150957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin induces liver injury by inhibiting the key enzymes of FADH/NADPH transport in rat liver.
    Yang X; Zhang Y; Liu Y; Chen C; Xu W; Xiao H
    Toxicol Res (Camb); 2018 Sep; 7(5):888-896. PubMed ID: 30310665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cordycepin Enhanced Therapeutic Potential of Gemcitabine against Cholangiocarcinoma via Downregulating Cancer Stem-Like Properties.
    Lee HK; Na YJ; Seong SM; Ahn D; Choi KC
    Biomol Ther (Seoul); 2024 May; 32(3):369-378. PubMed ID: 38589021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
    Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
    Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.
    Yang Y; Guo Y; Luo H; Wang M; Chen F; Cui H; Chen P; Yin Z; Li L; Dai Y; Zeng J; Zhao J
    Front Pharmacol; 2023; 14():1164827. PubMed ID: 37081969
    [No Abstract]   [Full Text] [Related]  

  • 14. The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.
    Zhang Q; Chen WW; Sun X; Qian D; Tang DD; Zhang LL; Li MY; Wang LY; Wu CJ; Peng W
    Int J Biol Sci; 2022; 18(8):3498-3527. PubMed ID: 35637953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies.
    Triantafillidis JK; Triantafyllidi E; Sideris M; Pittaras T; Papalois AE
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and associated cell signalling pathways underlying the anticancer properties of phytochemical compounds from
    Svitina H; Hamman JH; Gouws C
    Exp Ther Med; 2021 Aug; 22(2):852. PubMed ID: 34178125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression.
    Guo H; Liu F; Yang S; Xue T
    Oncol Lett; 2020 Nov; 20(5):167. PubMed ID: 32934734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer potential of emodin.
    Hsu SC; Chung JG
    Biomedicine (Taipei); 2012 Sep; 2(3):108-116. PubMed ID: 32289000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruscogenin induces ferroptosis in pancreatic cancer cells.
    Song Z; Xiang X; Li J; Deng J; Fang Z; Zhang L; Xiong J
    Oncol Rep; 2020 Feb; 43(2):516-524. PubMed ID: 31894321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.